<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02563314</url>
  </required_header>
  <id_info>
    <org_study_id>1408025</org_study_id>
    <secondary_id>ANSM</secondary_id>
    <nct_id>NCT02563314</nct_id>
  </id_info>
  <brief_title>Comparison of Two Oxygen Setting During Non-invasive Mechanical Ventilation of Chronic Obstructive Pulmonary Disease</brief_title>
  <acronym>OXYSET</acronym>
  <official_title>Comparison of Two Oxygen Setting During Non-invasive Mechanical Ventilation of Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Saint Etienne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Saint Etienne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypoxaemic patients with exacerbations of chronic obstructive pulmonary disease (COPD) are at
      some risk of carbon dioxide (CO2) retention during oxygen therapy. Main mechanism of CO2
      retention is believed to be reversal of preexisting regional hypoxic pulmonary
      vasoconstriction, resulting in a greater dead space. Risk of CO2 retention during mechanical
      ventilation remains controversial. Thus recent study suggested limited risk of CO2 retention
      with controlled oxygen supplementation during mechanical ventilation. Conversely, controlled
      oxygen supplementation might decrease dyspnea and respiratory workload, increase comfort and
      improve both urinary output and renal function.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 22, 2017</start_date>
  <completion_date type="Anticipated">September 2019</completion_date>
  <primary_completion_date type="Anticipated">September 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>urinary output (ml)</measure>
    <time_frame>24 hours</time_frame>
    <description>First 24 hours of non-invasive mechanical ventilation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in CO2 levels</measure>
    <time_frame>24 hours, 48 hours, 72hours</time_frame>
    <description>First 24 hours of non-invasive mechanical ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>respiratory workload during non-invasive mechanical ventilation (occlusion pressure (cm H2O) to 100 ms after the onset of inspiration)</measure>
    <time_frame>24 hours, 48 hours, 72 hours</time_frame>
    <description>First 24 hours of non-invasive mechanical ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum creatinine</measure>
    <time_frame>24 hours, 48 hours, 72hours</time_frame>
    <description>First 24 hours of non-invasive mechanical ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal resistive index</measure>
    <time_frame>24 hours, 48 hours, 72hours</time_frame>
    <description>First 24 hours of non-invasive mechanical ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulmonary arterial pressure</measure>
    <time_frame>24 hours, 48 hours, 72hours</time_frame>
    <description>First 24 hours of non-invasive mechanical ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Semiquantitative assessment of dyspnea (visual likert scale)</measure>
    <time_frame>24 hours, 48 hours, 72hours</time_frame>
    <description>First 24 hours of non-invasive mechanical ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Semiquantitative assessment of comfort (visual likert scale)</measure>
    <time_frame>24 hours, 48 hours, 72hours</time_frame>
    <description>First 24 hours of non-invasive mechanical ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fluid balance</measure>
    <time_frame>24 hours, 48 hours, 72hours</time_frame>
    <description>First 24 hours of non-invasive mechanical ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SOFA (Sequential Organ Failure Assessment) score</measure>
    <time_frame>24 hours, 48 hours, 72hours</time_frame>
    <description>First 24 hours of non-invasive mechanical ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>up to day 28</time_frame>
    <description>First 24 hours of non-invasive mechanical ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients requiring mechanical ventilation</measure>
    <time_frame>up to day 28</time_frame>
    <description>Evaluation until 28 days with an evaluation at intensive care unit discharge, and at hospital discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>days alive without mechanical ventilation</measure>
    <time_frame>up to day 28</time_frame>
    <description>Evaluation up to 28 days with an evaluation at intensive care unit discharge, and at hospital discharge</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">88</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease With Acute Exacerbation, Unspecified</condition>
  <arm_group>
    <arm_group_label>intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Non-invasive mechanical ventilation - Normoxia</intervention_name>
    <description>Maintenance of an oxygen setting allowing normal oxygen saturation during non-invasive mechanical ventilation (SpO2 targeted 96-98%)</description>
    <arm_group_label>intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Non-invasive mechanical ventilation - Controlled hypoxemia</intervention_name>
    <description>Maintenance of an oxygen setting allowing mild hypoxemia during non-invasive mechanical ventilation (SpO2 targeted 88-92%)</description>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years

          -  Acute hypercapnic COPD exacerbation

          -  Respiratory acidosis

          -  Intensive care unit admission

          -  Non-Invasive mechanical ventilation for less than 24 hours

          -  Patients or proxy consent

          -  Patients affiliated with the General Social Security Health System

        Exclusion Criteria:

          -  Pregnancy

          -  Sickle cells disease

          -  Acute coronary syndrome

          -  Restrictive respiratory disease

          -  Stage 4 or 5 chronic kidney disease

          -  COPD exacerbation following a first episode of conventional mechanical ventilation

          -  Contraindications to non-invasive ventilation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael DARMON, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de SAINT-ETIENNE</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michael DARMON, MD PhD</last_name>
    <phone>(0)477127853</phone>
    <phone_ext>+33</phone_ext>
    <email>michael.darmon@chu-st-etienne.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Carine LABRUYERE, CRA</last_name>
    <phone>(0)477120469</phone>
    <phone_ext>+33</phone_ext>
    <email>carine.labruyere@chu-st-etienne.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU de CLERMONT-FERRAND</name>
      <address>
        <city>Clermont-ferrand</city>
        <zip>63000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bertrand SOUWEINE, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHu de GRENOBLE</name>
      <address>
        <city>Grenoble</city>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Carole SCHWEBEL, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de la Pitié-Salpêtrière</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alexandre DEMOULE, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de SAINT-ETIENNE</name>
      <address>
        <city>Saint-etienne</city>
        <zip>42000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael DARMON, MD PhD</last_name>
      <phone>0477127853</phone>
      <phone_ext>+33</phone_ext>
      <email>michael.darmon@chu-st-etienne.fr</email>
    </contact>
    <investigator>
      <last_name>Michael DARMON, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 24, 2015</study_first_submitted>
  <study_first_submitted_qc>September 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 30, 2015</study_first_posted>
  <last_update_submitted>December 27, 2017</last_update_submitted>
  <last_update_submitted_qc>December 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Noninvasive Ventilation</keyword>
  <keyword>Pulmonary Disease</keyword>
  <keyword>Chronic Obstructive</keyword>
  <keyword>Renal Doppler</keyword>
  <keyword>Oxygen</keyword>
  <keyword>Hypercapnia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

